Hinesight Vision Care - Medicare Optometrist in Flowood, MS

Hinesight Vision Care is a medicare enrolled "Optometrist" provider in Flowood, Mississippi. Their current practice location is 1006 Treetops Blvd Ste 105, Flowood, Mississippi. You can reach out to their office (for appointments etc.) via phone at (601) 519-4466.

Hinesight Vision Care is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Hinesight Vision Care is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1497213383.

Contact Information

Hinesight Vision Care
1006 Treetops Blvd Ste 105,
Flowood, MS 39232-7645
(601) 519-4466
(601) 374-5737



Healthcare Provider's Profile

Full NameHinesight Vision Care
TypeFacility
SpecialityOptometrist
Location1006 Treetops Blvd Ste 105, Flowood, Mississippi
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1497213383
  • Provider Enumeration Date: 03/09/2019
  • Last Update Date: 10/28/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 1254664592
  • Enrollment ID: O20190531001247

Medical Identifiers

Medical identifiers for Hinesight Vision Care such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1497213383NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Hinesight Vision Care acts as a billing entity for following providers:
Provider NameNettie R Hines
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1386168730
PECOS PAC ID: 7618249608
Enrollment ID: I20170825002670

News Archive

Simple, effective portable tool can help predict avian flu outbreaks

A simple and effective portable tool to predict avian flu outbreaks on farms has been created by University of Guelph researchers.

Intellect Neurosciences locks database of OXIGON Phase 1b clinical trial for Alzheimer's disease

Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).

Oncotype DX assay linked to decrease in chemotherapy use in younger patients

In what's believed to be one of the largest population-based studies of Oncotype DX ever conducted, researchers at The University of Texas MD Anderson Cancer Center have found that the commercial diagnostic tool, Oncotype DX, was associated with a decrease in chemotherapy use in younger patients, but not in those over 66 years of age.

UIC Center for Alcohol Research in Epigenetics receives $8.2 million NIH grant

The University of Illinois at Chicago received $8.2 million from the National Institute on Alcohol Abuse and Alcoholism to continue the Center for Alcohol Research in Epigenetics and its research on how alcohol affects genes through epigenetics - chemical changes to DNA, RNA or proteins that alter the expression of genes without directly modifying them.

Read more Medical News

› Verified 1 days ago

Provider NameJenny H Jones
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1174902282
PECOS PAC ID: 7911335559
Enrollment ID: I20211014001308

News Archive

Simple, effective portable tool can help predict avian flu outbreaks

A simple and effective portable tool to predict avian flu outbreaks on farms has been created by University of Guelph researchers.

Intellect Neurosciences locks database of OXIGON Phase 1b clinical trial for Alzheimer's disease

Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).

Oncotype DX assay linked to decrease in chemotherapy use in younger patients

In what's believed to be one of the largest population-based studies of Oncotype DX ever conducted, researchers at The University of Texas MD Anderson Cancer Center have found that the commercial diagnostic tool, Oncotype DX, was associated with a decrease in chemotherapy use in younger patients, but not in those over 66 years of age.

UIC Center for Alcohol Research in Epigenetics receives $8.2 million NIH grant

The University of Illinois at Chicago received $8.2 million from the National Institute on Alcohol Abuse and Alcoholism to continue the Center for Alcohol Research in Epigenetics and its research on how alcohol affects genes through epigenetics - chemical changes to DNA, RNA or proteins that alter the expression of genes without directly modifying them.

Read more Medical News

› Verified 1 days ago

Provider NameAnna Lynn Nations
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1265165963
PECOS PAC ID: 2264807908
Enrollment ID: I20230411000181

News Archive

Simple, effective portable tool can help predict avian flu outbreaks

A simple and effective portable tool to predict avian flu outbreaks on farms has been created by University of Guelph researchers.

Intellect Neurosciences locks database of OXIGON Phase 1b clinical trial for Alzheimer's disease

Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).

Oncotype DX assay linked to decrease in chemotherapy use in younger patients

In what's believed to be one of the largest population-based studies of Oncotype DX ever conducted, researchers at The University of Texas MD Anderson Cancer Center have found that the commercial diagnostic tool, Oncotype DX, was associated with a decrease in chemotherapy use in younger patients, but not in those over 66 years of age.

UIC Center for Alcohol Research in Epigenetics receives $8.2 million NIH grant

The University of Illinois at Chicago received $8.2 million from the National Institute on Alcohol Abuse and Alcoholism to continue the Center for Alcohol Research in Epigenetics and its research on how alcohol affects genes through epigenetics - chemical changes to DNA, RNA or proteins that alter the expression of genes without directly modifying them.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Hinesight Vision Care is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Hinesight Vision Care
1006 Treetops Blvd Ste 105,
Flowood, MS 39232-7645

Ph: (601) 519-4466
Hinesight Vision Care
1006 Treetops Blvd Ste 105,
Flowood, MS 39232-7645

Ph: (601) 519-4466

News Archive

Simple, effective portable tool can help predict avian flu outbreaks

A simple and effective portable tool to predict avian flu outbreaks on farms has been created by University of Guelph researchers.

Intellect Neurosciences locks database of OXIGON Phase 1b clinical trial for Alzheimer's disease

Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).

Oncotype DX assay linked to decrease in chemotherapy use in younger patients

In what's believed to be one of the largest population-based studies of Oncotype DX ever conducted, researchers at The University of Texas MD Anderson Cancer Center have found that the commercial diagnostic tool, Oncotype DX, was associated with a decrease in chemotherapy use in younger patients, but not in those over 66 years of age.

UIC Center for Alcohol Research in Epigenetics receives $8.2 million NIH grant

The University of Illinois at Chicago received $8.2 million from the National Institute on Alcohol Abuse and Alcoholism to continue the Center for Alcohol Research in Epigenetics and its research on how alcohol affects genes through epigenetics - chemical changes to DNA, RNA or proteins that alter the expression of genes without directly modifying them.

Read more News

› Verified 1 days ago


Optometrist in Flowood, MS

M H Allen Llc
Optometrist
Medicare: Medicare Enrolled
Practice Location: 4810 Lakeland Dr, Flowood, MS 39232
Phone: 601-939-6366    Fax: 601-939-3482
Dr. Christopher Cockrum White, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 5341 Lakeland Dr, Flowood, MS 39232
Phone: 601-919-1300    Fax: 601-919-1133
Bomee Kim, OD
Optometrist
Medicare: May Accept Medicare Assignments
Practice Location: 1053 River Oaks Dr, Flowood, MS 39232
Phone: 601-969-1430    Fax: 601-709-2117
Sorey Eye Clinic
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 117 Luckney Station, Flowood, MS 39232
Phone: 601-992-7275    Fax: 601-992-7244
Nettie Hines, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1006 Treetops Blvd Ste 105, Flowood, MS 39232
Phone: 601-519-4466    Fax: 601-374-5737
Charles E Mcmasters Inc
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 120 Promenade Blvd, Flowood, MS 39232
Phone: 601-992-1010    Fax: 601-992-7700
Dr. Mark H Allen, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 4810 Lakeland Dr, Flowood, MS 39232
Phone: 601-932-1115    Fax: 601-939-3482

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.